What is Cue?
Cue is a connected, molecular diagnostic system
The Cue Health Monitoring System is a rapid, compact, highly portable testing platform with no compromise in performance or accuracy. It uses molecular diagnostic technology to deliver reliable results in about 20 minutes.
Who we work with
Cue is partnering with leading organizations such as BARDA, Henry Schein, Johnson & Johnson, Mayo Clinic, and the National Basketball Association to further our science and protect human health.
NewsroomView all press
Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot ProgramRead more
Cue’s CEO Ayub Khattak joins Lisa Ling on Season 2 of Johnson & Johnson’s COVID-19 Series: The Road to a VaccineRead more
Cue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million…Read more
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19…Read more
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing PlatformRead more
Cue Health Awarded $13 Million for Rapid, Portable, Point-of-Care COVID-19 Test by U.S. Department of Health and…Read more
One system, any industry
Accessible, accurate, scalable diagnostic testing for any industry, including healthcare, government, and education.
Made in the USA
Designed, engineered, manufactured, and tested in San Diego
Proudly headquartered in San Diego, Cue’s state-of-the-art space includes lab, office, and production facilities.